HER2-Displaying M13 Bacteriophages induce Therapeutic Immunity against Breast Cancer

SIMPLE SUMMARY: The high incidence and death rates of breast cancer make the development of new therapies an urgent need. The introduction into the clinic of the anti-HER2 monoclonal antibody trastuzumab considerably improved the overall survival and time-to-disease progression of patients with HER2...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Junbiao, Lamolinara, Alessia, Conti, Laura, Giangrossi, Mara, Cui, Lishan, Morelli, Maria Beatrice, Amantini, Consuelo, Falconi, Maurizio, Bartolacci, Caterina, Andreani, Cristina, Orlando, Fiorenza, Provinciali, Mauro, Del Pizzo, Francesco Domenico, Russo, Francesca, Belletti, Barbara, Riccardo, Federica, Bolli, Elisabetta, Quaglino, Elena, Cavallo, Federica, Amici, Augusto, Iezzi, Manuela, Marchini, Cristina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406369/
https://www.ncbi.nlm.nih.gov/pubmed/36011047
http://dx.doi.org/10.3390/cancers14164054

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406369/
https://www.ncbi.nlm.nih.gov/pubmed/36011047
http://dx.doi.org/10.3390/cancers14164054

Ejemplares similares